Medicare Enrolled

Dr. Leigh Ann Barbaree, NP

Nurse Practitioner - Family · Columbus, GA
Low-engagement
3934 WOODRUFF RD, Columbus, GA 31904
7063220304
In practice since 2008 (17 years)
NPI: 1184889867 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Barbaree from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Barbaree? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Barbaree

Dr. Leigh Ann Barbaree is a nurse practitioner - family in Columbus, GA, with 17 years of NPI registration.

Between the years covered by Open Payments, Dr. Barbaree received a total of $6,331 from 44 pharmaceutical and/or device companies across 405 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Barbaree is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice $6,331 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$6,331
Total received (2021-2024)
Avg $1,583/year across 4 years
Top 3% in GA for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
405
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,331 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,033
2023
$1,601
2022
$1,589
2021
$1,107

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Bayer Healthcare Pharmaceuticals Inc.
$221
Novo Nordisk Inc
$204
Lilly USA, LLC
$193
Ardelyx, Inc.
$190
AstraZeneca Pharmaceuticals LP
$166
Boston Scientific Corporation
$143
Daiichi Sankyo Inc.
$122
Sumitomo Pharma America, Inc.
$108
ABBVIE INC.
$86
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$72
Phathom Pharmaceuticals, Inc.
$67
Astellas Pharma US Inc
$64
GlaxoSmithKline, LLC.
$61
Amgen Inc.
$56
Inspire Medical Systems, Inc.
$53
Axsome Therapeutics, Inc.
$38
Novartis Pharmaceuticals Corporation
$34
Mylan Specialty L.P.
$24
Abbott Laboratories
$23
E.R. Squibb & Sons, L.L.C.
$22
Otsuka America Pharmaceutical, Inc.
$20
Mannkind Corporation
$19
Takeda Pharmaceuticals U.S.A., Inc.
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
Paratek Pharmaceuticals, Inc.
$14
Top 3 companies account for 30.4% of 2024 payments
All-time payments by company (2021-2024) ›
Novo Nordisk Inc
$967
ABBVIE INC.
$673
Lilly USA, LLC
$631
Bayer Healthcare Pharmaceuticals Inc.
$306
Astellas Pharma US Inc
$271
AstraZeneca Pharmaceuticals LP
$250
AbbVie Inc.
$225
PFIZER INC.
$222
Novartis Pharmaceuticals Corporation
$198
Ardelyx, Inc.
$190
GlaxoSmithKline, LLC.
$169
Amgen Inc.
$166
Takeda Pharmaceuticals U.S.A., Inc.
$163
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$160
Biohaven Pharmaceutical Holding Company Ltd.
$160
Boston Scientific Corporation
$143
Eisai Inc.
$135
Daiichi Sankyo Inc.
$122
Axsome Therapeutics, Inc.
$120
Boehringer Ingelheim Pharmaceuticals, Inc.
$114
Sumitomo Pharma America, Inc.
$108
Bayer HealthCare Pharmaceuticals Inc.
$91
Mylan Specialty L.P.
$85
Esperion Therapeutics, Inc.
$80
Phathom Pharmaceuticals, Inc.
$67
SANOFI-AVENTIS U.S. LLC
$63
Inspire Medical Systems, Inc.
$53
JAZZ PHARMACEUTICALS INC.
$46
Xeris Pharmaceuticals, Inc.
$42
Horizon Therapeutics plc
$42
Otsuka America Pharmaceutical, Inc.
$37
E.R. Squibb & Sons, L.L.C.
$33
Abbott Laboratories
$23
Amarin Pharma Inc.
$20
Mannkind Corporation
$19
Dexcom, Inc.
$18
Corium, LLC
$18
Seqirus USA Inc
$17
Nestle HealthCare Nutrition Inc.
$15
Biohaven Pharmaceuticals, Inc.
$14
Paratek Pharmaceuticals, Inc.
$14
Exact Sciences Corporation
$13
Janssen Pharmaceuticals, Inc
$13
DEXCOM, INC.
$12
Top 3 companies account for 35.9% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AIRSUPRA · AREXVY · AZSTARYS · Aimovig · Auvelity · BAQSIMI · BREZTRI · COMIRNATY · CREON · CUVITRU · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FLUCELVAX QUADRIVALENT · GEMTESA · GVOKE HYPOPEN · IBSRELA · INJECTAFER · INSPIRE · JARDIANCE · Kerendia · LEQVIO · LINZESS · MOUNJARO · MYRBETRIQ · Myrbetriq · NEXLETOL · NEXLIZET · NURTEC ODT · NUZYRA · Otezla · Ozempic · PENNSAID · PREVNAR 20 · QULIPTA · RAYOS · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA 100/33 · SUNOSI · Saxenda · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TRUMENBA · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Veozah · WATCHMAN FLX · Wegovy · XARELTO · XIFAXAN · YUPELRI · Yupelri · ZENPEP · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for nurse practitioner - family in GA.

Looking for a nurse practitioner - family in Columbus?
Compare family nurse practitioners in the Columbus area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
331
Per 100K population
162.0
County median income
$56,622
Nearest hospital
JACK HUGHSTON MEMORIAL HOSPITAL
4.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Barbaree is a nurse practitioner - family, with low-engagement industry engagement in the top 3% of GA peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Barbaree receive payments from pharmaceutical companies?
Yes. Dr. Barbaree received a total of $6,331 from 44 companies across 405 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Barbaree) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →